肺癌手术市场规模、份额和成长分析（按设备类型、类型、最终用户和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，肺癌手术市场价值将达到 61.2 亿美元，到 2025 年将成长至 63.7 亿美元，到 2033 年将成长至 87.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.1%。

肺癌手术市场是医疗保健领域至关重要且充满活力的行业，其发展主要受全球肺癌高发病率和高死亡率的驱动。包括微创手术（如胸腔镜辅助手术 (VATS) 和机器人辅助手术）在内的创新手术技术正被日益广泛地采用，以减轻患者疼痛并加快康復速度，从而改善患者预后。推动市场成长的因素包括肺癌发生率的上升、早期检测意识的增强以及手术技术的进步。儘管持续的研究正在推动手术效果的改善和新技术的探索，但高成本和先进手术的普及程度有限等挑战仍然存在。总体而言，主要行业参与者之间的合作正在推动手术实践的改进，确保更多患者获得有效的治疗，并在肺癌治疗过程中拥有更高的生活品质。

肺癌手术市场驱动因素

肺癌，尤其是开发中国家日益严重的烟草危机，已成为全球男性和女性的主要死因之一。肺癌病例和死亡人数的惊人增长构成了一项重大的全球健康挑战。肺癌不仅对患者本身造成影响，也对其家庭造成沉重打击，凸显了其严重的公共卫生问题。肺癌被定义为由肺组织细胞不受控制增殖引起的恶性肿瘤，其发病率的不断上升凸显了采取有效手术干预和综合治疗策略以对抗这种毁灭性疾病的紧迫性。

肺癌手术市场的限制

肺癌手术市场面临诸多挑战，可能阻碍其成长。其中一个主要限制因素是手术费用高昂，这可能会限制许多患者的就医机会。此外，一些国家也面临技术限制，进一步阻碍了市场发展。国际认证和资质审核流程漫长，也可能减缓该领域的进展。此外，医疗技术领域的激烈竞争也增加了市场的复杂性，因为企业难以在众多产品中脱颖而出，从而影响了市场的整体扩张潜力。

肺癌手术市场趋势

肺癌手术市场正呈现显着的研发成长趋势，旨在改善患者预后并提高手术精准度。临床试验数量激增，凸显了标靶治疗和免疫疗法等创新治疗方法作为传统手术治疗方法之外的极具前景的替代方案。此外，微创手术技术的进步正在改变产业格局，使患者能够更快康復并享受更高的生活品质。随着相关人员寻求整合最尖端科技并改进现有流程，这种创新驱动力预计将推动市场成长，最终革新肺癌治疗。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术评估
• 监管环境
• 疾病流行病学
• 专利分析

全球肺癌手术市场规模（按器材类型和复合年增长率划分）（2026-2033 年）

• 手术器械
  • 电动手术器械
  • 手动仪器
  • 订书机
  • 钳子
  • 牵开器
  • 肋骨剪刀
  • 刀具
  • 夹钳
  • 剪刀
  • 套管针
  • 电梯
  • 其他的
• 监控和视觉化系统
  • 摄影机和影像支援系统
  • 具有光学可视化的内视镜套管
• 内视镜手术设备

全球肺癌手术市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 开胸手术
  • 切除术
  • 袖状切除术
  • 切除术
  • 肺切除术
• 微创手术

全球肺癌手术市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 医院
• 门诊手术中心

全球肺癌手术市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Ethicon Llc.（Johnson & Johnson Group）
• Medtronic Plc.
• Olympus Corporation
• Intuitive Surgical Inc.
• Siemens Healthineers
• Teleflex Incorporated
• Accuray Incorporated
• Angiodynamics Inc.
• Key Surgical Llc.
• KLS Martin Group
• Ackermann Instrumente Gmbh
• Karl Storz Gmbh
• Scanlan International, Inc.
• Trokamed Gmbh
• Surgical Holdings
• Fusionkraft Surgical Instruments
• Richard Wolf Gmbh
• Sontec Instruments Inc.
• Wexler Surgical Inc.
• Phoenix Surgical Instruments Ltd.（Steris Ims）

结论与建议

Lung Cancer Surgery Market size was valued at USD 6.12 Billion in 2024 and is poised to grow from USD 6.37 Billion in 2025 to USD 8.79 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The Lung Cancer Surgery market is a vital and dynamic sector within healthcare, driven by the high prevalence and mortality associated with lung cancer globally. Innovative surgical techniques, such as minimally invasive approaches including video-assisted thoracic surgery (VATS) and robotic-assisted procedures, are increasingly adopted, enhancing patient outcomes through reduced pain and quicker recovery times. Factors propelling market growth include the rising incidence of lung cancer, heightened awareness surrounding early detection, and advancements in surgical technologies. Ongoing research aims to refine surgical outcomes and explore novel methods, while challenges like high costs and limited access to sophisticated procedures persist. Overall, collaboration among major industry players aims to improve surgical practices, ensuring more patients receive effective interventions and a better quality of life in lung cancer treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lung Cancer Surgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lung Cancer Surgery Market Segments Analysis

Global Lung Cancer Surgery Market is segmented by Device Type, Type, End-User and Region. Based on Device Type, the market is segmented into Surgical instruments, Monitoring & Visualizing Systems, Endosurgical Equipment. Based on Type, the market is segmented into Thoracotomy, Minimally Invasive Surgeries. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgery Centres. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lung Cancer Surgery Market

Lung cancer stands as the leading cause of death for both men and women across the globe, driven largely by the escalating tobacco crisis prevalent in developing nations. This alarming rise in lung cancer cases and fatalities poses a substantial health challenge worldwide. The repercussions of lung cancer are profound, affecting not only the patients but also their families, highlighting its status as a critical public health concern. Defined as a malignant growth resulting from the uncontrolled growth of lung tissue cells, lung cancer's increasing incidence underscores the urgent need for effective surgical interventions and comprehensive treatment strategies to combat this devastating disease.

Restraints in the Lung Cancer Surgery Market

The lung cancer surgery market faces several challenges that may hinder its growth. One significant constraint is the high expense associated with the surgical procedures, which can restrict access for many patients. Additionally, certain countries encounter technical limitations that further impede market development. The lengthy process required for international certifications and qualifications can also slow down advancements in the field. Moreover, fierce competition within the medical technology sector adds another layer of complexity, as companies strive to stand out amidst a myriad of options, ultimately affecting the market's overall expansion potential.

Market Trends of the Lung Cancer Surgery Market

The lung cancer surgery market is experiencing a significant trend towards increasing research and development efforts aimed at enhancing patient outcomes and surgical precision. A surge in clinical trials is being observed, focusing on innovative treatment modalities such as targeted therapies and immunotherapies, which offer promising alternatives to traditional surgical options. Additionally, advancements in minimally invasive surgical techniques are revolutionizing the landscape, providing patients with reduced recovery times and improved quality of life. This commitment to innovation is expected to drive market growth, as stakeholders seek to integrate cutting-edge technologies and refine existing procedures, ultimately transforming lung cancer care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Disease Epidemiology
• Patent Analysis

Global Lung Cancer Surgery Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Surgical instruments
  • Powdered Surgical Instruments
  • Hand Instruments
  • Staplers
  • Forceps
  • Retractors
  • Rib Shears
  • Cutters
  • Clamps
  • Scissors
  • Trocars
  • Elevators
  • Others
• Monitoring & Visualizing Systems
  • Cameras and Video Support
  • Endoscopic Trocars with Optical Views
• Endosurgical Equipment

Global Lung Cancer Surgery Market Size by Type & CAGR (2026-2033)

• Market Overview
• Thoracotomy
  • Lobectomy
  • Sleeve Resection
  • Segmentectomy
  • Pneumonectomy
• Minimally Invasive Surgeries

Global Lung Cancer Surgery Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgery Centres

Global Lung Cancer Surgery Market Size & CAGR (2026-2033)

• North America (Device Type, Type, End-User)
  • US
  • Canada
• Europe (Device Type, Type, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Device Type, Type, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Device Type, Type, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Type, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Ethicon Llc. (Johnson & Johnson Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiodynamics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Key Surgical Llc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ackermann Instrumente Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karl Storz Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scanlan International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trokamed Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgical Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fusionkraft Surgical Instruments
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf Gmbh
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sontec Instruments Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wexler Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phoenix Surgical Instruments Ltd. (Steris Ims)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation